Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Centers for Disease Control and Prevention

# AGENCY:

Centers for Disease Control and Prevention, Department of Health and Human Services (HHS).

# ACTION:

Notice.

# SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces an amendment to the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC).

# SUPPLEMENTARY INFORMATION:

                    Notice is hereby given of a change in the meeting of Board of Scientific Counselors, National Center for Injury Prevention and Control; January 11, 2024, first session from 10 a.m. to 12:05 p.m., EST (OPEN), and second session from 1 p.m. to 4:30 p.m., EST (CLOSED), in the original                     **Federal Register**                     notice.                

                    The notice of the virtual meeting was published in the                     **Federal Register**                     on November 17, 2023, 88 FR 80305.                

                    The meeting notice is being amended. The closed session that was scheduled for January 11, 2024, from 1 p.m. to 4:30 p.m., EST, has been canceled. The notice is being amended to update the                     **Summary**                    ,                     **Dates**                    ,                     **Addresses**                    , and                     **Supplementary Information**                     and should read as follows:                

# SUMMARY:

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC). This meeting is open to the public. Time will be available for public comment.

# DATES:

The meeting will be held on January 11, 2024, from 10 a.m. to 12:05 p.m., EST. The public comment period will be from 11:45 a.m. to 12 p.m., EST.

# ADDRESSES:

                        Webinar, Atlanta, Georgia. All participants must register by using the following link to attend the meeting:                         *https://cdc.zoomgov.com/​meeting/​register/​vJItf-igpjopGsXuGUhsdlIOmRCB2yx509k.*

# SUPPLEMENTARY INFORMATION:

*Purpose:*                         The Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC) will: (1) conduct, encourage, cooperate with, and assist other appropriate public health authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to the causes and strategies related to the prevention of injury, overdose, and violence; (2) assist States and other entities in preventing intentional and unintentional injuries, and to promote health and well-being; and (3) make recommendations of grants and cooperative agreements for research and prevention activities related to injury, overdose, and violence. The BSC, NCIPC makes recommendations regarding policies, strategies, objectives, and priorities and reviews progress toward injury, overdose, and violence prevention. The Board also provides advice on the appropriate balance of intramural and extramural research and provides guidance on the needs, structure, progress, and performance of intramural programs. Further, the Board provides guidance on extramural scientific program matters. Additionally, the Board provides second-level scientific and programmatic review of applications for research grants, cooperative agreements, and training grants related to injury, overdose, and violence prevention, and recommends approval of projects that merit further consideration for funding support. The Board also provides feedback and input on strategic plans, resources, and priority publications related to injury, overdose, and violence prevention.                    

*Matters To Be Considered:*                         The meeting will include a discussion on the updated Intimate Partner Violence Research Priorities. Agenda items are subject to change as priorities dictate.                    

# FOR FURTHER INFORMATION CONTACT:

                        Christopher R. Harper, Ph.D., Designated Federal Officer, Board of Scientific Counselors, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S-1069, Atlanta, Georgia 30341. Telephone: (404) 718-8330; Email:                         *ncipcbsc@cdc.gov.*

                        The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign                         **Federal Register**                         notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.                    

Kalwant Smagh,

Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2024-01165 Filed 1-22-24; 8:45 am]

BILLING CODE 4163-18-P